TG and neoplasm: Meanwhile, further study with a larger case population is also in need to validate the efficacy of plasma miR-323 and its correlation with serum/tissue Tg as a biomarker to evaluate the tumor progression, prognosis, and recurrence in clinical patients with PTC.